lorazepam
Generic: lorazepam
Labeler: aurolife pharma llcDrug Facts
Product Profile
Brand Name
lorazepam
Generic Name
lorazepam
Labeler
aurolife pharma llc
Dosage Form
TABLET
Routes
Active Ingredients
lorazepam 1 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
13107-084
Product ID
13107-084_67012944-0947-4e64-adab-869993f2f709
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA203572
DEA Schedule
civ
Listing Expiration
2026-12-31
Marketing Start
2021-02-01
Pharmacologic Class
Established (EPC)
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
13107084
Hyphenated Format
13107-084
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lorazepam (source: ndc)
Generic Name
lorazepam (source: ndc)
Application Number
ANDA203572 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 1 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (13107-084-01)
- 500 TABLET in 1 BOTTLE (13107-084-05)
- 10 TABLET in 1 BOTTLE (13107-084-10)
- 1000 TABLET in 1 BOTTLE (13107-084-99)
Packages (4)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "67012944-0947-4e64-adab-869993f2f709", "openfda": {"nui": ["N0000175694", "M0002356"], "upc": ["0313107083013", "0313107084010", "0313107085017"], "unii": ["O26FZP769L"], "rxcui": ["197900", "197901", "197902"], "spl_set_id": ["5b851f67-309d-4ef3-8b4b-ade8908256ea"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "manufacturer_name": ["Aurolife Pharma LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (13107-084-01)", "package_ndc": "13107-084-01", "marketing_start_date": "20210201"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (13107-084-05)", "package_ndc": "13107-084-05", "marketing_start_date": "20210201"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE (13107-084-10)", "package_ndc": "13107-084-10", "marketing_start_date": "20210201"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (13107-084-99)", "package_ndc": "13107-084-99", "marketing_start_date": "20210201"}], "brand_name": "LORAZEPAM", "product_id": "13107-084_67012944-0947-4e64-adab-869993f2f709", "dosage_form": "TABLET", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]"], "product_ndc": "13107-084", "dea_schedule": "CIV", "generic_name": "LORAZEPAM", "labeler_name": "Aurolife Pharma LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LORAZEPAM", "active_ingredients": [{"name": "LORAZEPAM", "strength": "1 mg/1"}], "application_number": "ANDA203572", "marketing_category": "ANDA", "marketing_start_date": "20210201", "listing_expiration_date": "20261231"}